title: Atypical neuroleptic malignant syndrome caused by clozapine and venlafaxine: early brief treatment with dantrolene.
authors.forename: Vittorio
authors.initials: V
authors.lastname: Ferioli
authors.forename: Allesandra
authors.initials: A
authors.lastname: Manes
authors.forename: Chiara
authors.initials: C
authors.lastname: Melloni
authors.forename: Samuele
authors.initials: S
authors.lastname: Nanni
authors.forename: Giancarlo
authors.initials: G
authors.lastname: Boncompagni
mesh_terms: D000328:Adult; D003024:Clozapine / Q000009:adverse effects*; D003511:Cyclohexanols / Q000009:adverse effects*; D003620:Dantrolene / Q000627:therapeutic use*; D018756:GABA Antagonists / Q000009:adverse effects*; D006801:Humans; D008297:Male; D009125:Muscle Relaxants, Central / Q000627:therapeutic use*; D009459:Neuroleptic Malignant Syndrome / Q000188:drug therapy* / Q000209:etiology*; D017367:Selective Serotonin Reuptake Inhibitors / Q000009:adverse effects*; D013997:Time Factors; D000069470:Venlafaxine Hydrochloride
chemical_list: D003024:Clozapine; D003511:Cyclohexanols; D003620:Dantrolene; D018756:GABA Antagonists; D009125:Muscle Relaxants, Central; D017367:Selective Serotonin Reuptake Inhibitors; D000069470:Venlafaxine Hydrochloride